Pages that link to "Q48256339"
Jump to navigation
Jump to search
The following pages link to Remifentanil for the insertion and removal of long-term central venous access during monitored anesthesia care (Q48256339):
Displaying 7 items.
- Short-term use of remifentanil during endotracheal extubation for prophylactic analgesia in neurosurgical patients after craniotomy (SURE after Craniotomy Study): a study protocol and statistical analysis plan for a randomised controlled trial (Q34264794) (← links)
- Randomized controlled trials in central vascular access devices: A scoping review (Q36316517) (← links)
- A phase II study on the efficacy and safety of procedural analgesia with fentanyl buccal tablet in cancer patients for the placement of indwelling central venous access systems. (Q36614999) (← links)
- Additional Analgesia for Central Venous Catheter Insertion: A Placebo Controlled Randomized Trial of Dexmedetomidine and Fentanyl (Q41007334) (← links)
- Effects of dexmedetomidine on procedural pain and discomfort associated with central venous catheter insertion (Q42117986) (← links)
- Pain and discomfort management during central venous catheter insertion (Q42129815) (← links)
- Effects of fentanyl on procedural pain and discomfort associated with central venous catheter insertion: A prospective, randomized, double-blind, placebo controlled trial (Q42139646) (← links)